Table of contents


In this issue

p399 | doi:10.1038/nrc831

Top

Research Highlights

Tumorigenesis: Origins

p401 | doi:10.1038/nrc826

Epigenetics: Breaking the silence

p402 | doi:10.1038/nrc825

Therapeutics: Controlled destruction

p402 | doi:10.1038/nrc834

Ongogenesis: A life or death situation

p403 | doi:10.1038/nrc827

Tumour–stroma interactions:: The causes of crime

p404 | doi:10.1038/nrc829

Chemoprevention: Long-distance relationship

p404 | doi:10.1038/nrc830

P53 regulation: Hitting the G spot

p405 | doi:10.1038/nrc828

Web Watch

Microarray mania

p405 | doi:10.1038/nrc837

Drug resistance: Resisting arrest

p406 | doi:10.1038/nrc833

Trial Watch

Anti-angiogenics

p406 | doi:10.1038/nrc836

Genomic instability: Two worlds collide

p407 | doi:10.1038/nrc832

News in Brief

Therapeutics | Tumour suppressors | Oncogenes | Therapeutics

p407 | doi:10.1038/nrc835

Top

Focus on: Stem Cells

Reviews

Gene therapy to protect haematopoietic cells from cytotoxic cancer drugs

Brian P. Sorrentino

p431 | doi:10.1038/nrc823

Top

Reviews

Modulating T-cell immunity to tumours: new strategies for monitoring T-cell responses

Cassian Yee & Philip Greenberg

p409 | doi:10.1038/nrc820

Targeting death and decoy receptors of the tumour-necrosis factor superfamily

Avi Ashkenazi

p420 | doi:10.1038/nrc821

Epithelial–mesenchymal transitions in tumour progression

Jean Paul Thiery

p442 | doi:10.1038/nrc822

Mechanisms of smoking-related lung and pancreatic adenocarcinoma development

Hildegard M. Schuller

p455 | doi:10.1038/nrc824

Top

Perspectives

Timeline

Fortuitous convergences: the beginnings of JUN

Peter K. Vogt

p465 | doi:10.1038/nrc818

Opinion

Histone methyltransferases, diet nutrients and tumour suppressors

Shi Huang

p469 | doi:10.1038/nrc819

Natureview: Reviews and comment from the nature publishing group

p477 | doi:10.1038/nrc838

Extra navigation

Subscribe

Subscribe to Nature Reviews Cancer

naturejobs

Advertisement